Effect of an antibiotic stewardship programme on acute kidney injury among cancer survivors
Published
December 23, 2025
Paper ID
PAP-000244
Status
Published
DOI
10.65712/tmj.test000502
Advance Services
Abstract
Background: The cost of acute kidney injury to health systems is substantial. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. acute kidney injury occurred in 20% of the intervention group versus 35% of controls. Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Guidelines make only a weak recommendation on an antibiotic stewardship programme. Earlier studies of an antibiotic stewardship programme were small or single-centre.
Guidelines make only a weak recommendation on an antibiotic stewardship programme. acute kidney injury remains a leading cause of avoidable harm among cancer survivors.
Guidelines make only a weak recommendation on an antibiotic stewardship programme. acute kidney injury remains a leading cause of avoidable harm among cancer survivors. The cost of acute kidney injury to health systems is substantial.
Practice around an antibiotic stewardship programme varies widely between centres. Guidelines make only a weak recommendation on an antibiotic stewardship programme.
Materials and Methods
Eligible participants were cancer survivors. The primary outcome was acute kidney injury, assessed blind to allocation.
Missing data were handled with multiple imputation. The primary outcome was acute kidney injury, assessed blind to allocation. Eligible participants were cancer survivors.
We conducted a randomised controlled trial across 10 centres between 2017 and 2023. Eligible participants were cancer survivors.
Analyses were adjusted for age, sex and baseline severity. The primary outcome was acute kidney injury, assessed blind to allocation. We conducted a randomised controlled trial across 5 centres between 2019 and 2021.
Results
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.61 (95% CI 0.38 to 0.80).
| Group | n | Events | Rate % |
|---|---|---|---|
| Centre B | 721 | 35 | 22.8 |
| Male | 209 | 34 | 32.2 |
| Centre A | 388 | 27 | 32.6 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.

Shown for cancer survivors; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.38 (95% CI 0.42 to 0.86). Serious adverse events were rare and similar between groups. 365 participants were included (median age 42 years).
acute kidney injury occurred in 11% of the intervention group versus 35% of controls. acute kidney injury occurred in 18% of the intervention group versus 14% of controls.
Discussion
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Conclusions
An antibiotic stewardship programme may be offered for cancer survivors to improve acute kidney injury.
References
1. Lindqvist X, Ibrahim L, et al. A sepsis alert system and acute kidney injury. Crit Care Med. 2014;390(5):331-1063.
2. Rossi U, Mueller W, et al. Early mobilisation and medication adherence. JAMA. 2015;95(10):202-1717.
3. Ahmed Z, Larsen L, et al. An antibiotic stewardship programme and health-related quality of life. N Engl J Med. 2015;24(2):860-1738.
4. Rossi C, Tanaka A, et al. Delayed cord clamping and patient satisfaction. Eur Heart J. 2014;163(1):486-1305.
5. Mueller G, Costa J, et al. SGLT2 inhibitors and medication adherence. Diabetes Care. 2025;127(5):792-1126.
6. Schmidt F, Zhang B, et al. An enhanced recovery pathway and length of stay. JAMA. 2009;115(12):896-1267.
Appendices
Ethics approval: IRB-5749.